Stock GNMK GENMARK DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GENMARK DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
GENMARK INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenMark Diagnostics - GNMK
BU
GENMARK DIAGNOSTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
GENMARK DIAGNOSTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
GenMark Diagnostics: 4Q Earnings Snapshot
AQ
GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
GL
GENMARK DIAGNOSTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
GL
GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference
GL
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
GL
GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
GL
GenMark Diagnostics : GNMK January 2021 Investor Presentation
PU
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
GL
GenMark Diagnostics to Participate in Upcoming Investor Conferences
GL
GenMark Diagnostics : to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
AQ
GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
GL
GenMark Diagnostics : GNMK November 2020 Investor Presentation
PU
GenMark Diagnostics: 3Q Earnings Snapshot
AQ
GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GNMK Stock
  4. News GenMark Diagnostics, Inc.
  5. Press Releases